Gilteritinib is a targeted therapy for the treatment of specific types of leukemia. Currently, the price in the domestic market is approximately 30,000 to 40,000 RMB per box, but the exact price may fluctuate depending on factors such as specifications, region, and medical insurance policies. This drug requires a prescription and must be used strictly according to the doctor's instructions.
Main Factors Affecting Price
Specification Differences: The price varies depending on the packaging specifications of gilteritinib (e.g., the number of tablets per box).
Medical Insurance Policies: Gilteritinib was included in the National Medical Insurance Catalog in 2023. Reimbursement rates vary depending on regional policies, and the out-of-pocket cost for some patients may be reduced to 15,000 to 25,000 RMB per box.
Purchase Channels: Prices may differ between hospitals, designated pharmacies, and overseas purchase channels. It is essential to purchase through legitimate channels.
Precautions for Use
Indication Restrictions: This drug is only indicated for adult patients with relapsed or refractory acute myeloid leukemia (AML) carrying the FLT3 gene mutation. Eligibility must be confirmed through genetic testing.
Side Effect Management: Common side effects include abnormal liver function and muscle pain. Regular monitoring and dosage adjustments under a doctor's guidance are necessary.
Contraindications and Interactions: This medication may interact with other drugs (such as anticoagulants and immunosuppressants). Patients should inform their doctor of their current medication history.
Obtaining the Medication:
Hospital Pharmacies: This medication is usually stocked in the oncology or hematology departments of tertiary hospitals. A prescription is required.
Designated Medical Insurance Pharmacies: Patients eligible for medical insurance reimbursement can apply for medication by bringing their prescription and supporting documents.
Special Purchase Channels: In some regions, costs can be reduced through a "dual-channel" mechanism or charitable assistance programs. Consult your attending physician or the hospital pharmacy department.
Price Fluctuations and Latest Information
Drug prices may be updated due to policy adjustments and changes in market supply. It is recommended to obtain real-time information through the following methods:
Contact the pharmacy department or medical insurance office of the hospital where you are receiving treatment.
Call the official customer service hotline of the drug manufacturer.
Pay attention to announcements from the National Healthcare Security Administration or local medical insurance departments.
Important Note: Gefitinib is a prescription drug and should be used under the guidance of a hematologist or oncologist. Do not adjust the dosage or discontinue use on your own. Regular blood tests, liver and kidney function tests, and genetic testing are necessary during treatment. If severe adverse reactions occur (such as difficulty breathing or persistent high fever), seek immediate medical attention.
